191 related articles for article (PubMed ID: 17080031)
1. Drug discovery in dementia: the role of rodent models.
Van Dam D; De Deyn PP
Nat Rev Drug Discov; 2006 Nov; 5(11):956-70. PubMed ID: 17080031
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
Chabrier PE
Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
[TBL] [Abstract][Full Text] [Related]
3. Animal models of dementia and cognitive dysfunction.
Neha ; Sodhi RK; Jaggi AS; Singh N
Life Sci; 2014 Jul; 109(2):73-86. PubMed ID: 25066372
[TBL] [Abstract][Full Text] [Related]
4. Of mice and men: more neurobiology in dementia.
Codita A; Winblad B; Mohammed AH
Curr Opin Psychiatry; 2006 Nov; 19(6):555-63. PubMed ID: 17012931
[TBL] [Abstract][Full Text] [Related]
5. Animal models of Alzheimer's disease and frontotemporal dementia.
Götz J; Ittner LM
Nat Rev Neurosci; 2008 Jul; 9(7):532-44. PubMed ID: 18568014
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
7. A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.
Cummings J; Winblad B
Expert Rev Neurother; 2007 Nov; 7(11):1457-63. PubMed ID: 17997695
[TBL] [Abstract][Full Text] [Related]
8. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease.
Boudrault C; Bazinet RP; Ma DW
J Nutr Biochem; 2009 Jan; 20(1):1-10. PubMed ID: 18824343
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin enhances learning and memory independent of amyloid load in mice.
Li L; Cao D; Kim H; Lester R; Fukuchi K
Ann Neurol; 2006 Dec; 60(6):729-39. PubMed ID: 17192930
[TBL] [Abstract][Full Text] [Related]
11. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
Ostrovskaya RU; Gruden MA; Bobkova NA; Sewell RD; Gudasheva TA; Samokhin AN; Seredinin SB; Noppe W; Sherstnev VV; Morozova-Roche LA
J Psychopharmacol; 2007 Aug; 21(6):611-9. PubMed ID: 17092975
[TBL] [Abstract][Full Text] [Related]
12. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).
Ishrat T; Hoda MN; Khan MB; Yousuf S; Ahmad M; Khan MM; Ahmad A; Islam F
Eur Neuropsychopharmacol; 2009 Sep; 19(9):636-47. PubMed ID: 19329286
[TBL] [Abstract][Full Text] [Related]
14. The brain as a target for inflammatory processes and neuroprotective strategies.
Skaper SD
Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
[TBL] [Abstract][Full Text] [Related]
15. Rivastigmine in Parkinson's disease dementia.
Chitnis S; Rao J
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
[TBL] [Abstract][Full Text] [Related]
16. Current issues in dementia pharmacotherapy.
Daiello LA
Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783
[TBL] [Abstract][Full Text] [Related]
17. Tauopathy models and human neuropathology: similarities and differences.
Frank S; Clavaguera F; Tolnay M
Acta Neuropathol; 2008 Jan; 115(1):39-53. PubMed ID: 17786456
[TBL] [Abstract][Full Text] [Related]
18. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
Arnett HA; Viney JL
Adv Drug Deliv Rev; 2007 Sep; 59(11):1084-92. PubMed ID: 17804112
[TBL] [Abstract][Full Text] [Related]
19. Disease-modifying therapies in Alzheimer's disease.
Salloway S; Mintzer J; Weiner MF; Cummings JL
Alzheimers Dement; 2008 Mar; 4(2):65-79. PubMed ID: 18631951
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.
Gupta M; Kaur H; Grover S; Kukreti R
Pharmacogenomics; 2008 Jul; 9(7):895-903. PubMed ID: 18597653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
